0215. Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

Bommenel, T; Meynard, JL; Launay, O; Simon, A; Mahamat, A; Martinez, V; Gilquin, J; Katlama, C; Lascaux, AS; Pradier, C; Rouveix, E; Costagliola, D; Abgrall, S

doi:10.1186/1758-2652-13-S4-O21

Journal of the International AIDS Society

Article metrics
Last updated: Thu, 25 Apr 2024 7:10:53 Z

0215. Virological outcomes in ARV-naïve patients switching or not from a first successful boosted PI-regimen to efavirenz, nevirapine or abacavir regimens

Access & Citations

2021

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.